Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2025-06-24 00:00:00 ET · period of report 2025-06-23 · accession 0001415889-25-018128 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-24 | 2025-06-23+ | ORIC | Piscitelli Dominic | CFO | S - Sale | $10.48 | -33.5K | 68.3K | -33% | -$351.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-23 | S | D | 584 | $10.00 | 101,233 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-23 | S | D | 450 | $10.01 | 100,783 | D | — | — | |
| 3 | Common | Common Stock | 2025-06-24 | S | D | 32,466 | $10.50 | 68,317 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 32,466 shares sold in the price range of $10.34 to $10.80 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |